CLINICAL-NEUROLOGICAL AND NEUROPHYSIOLOGICAL CHANGES IN CHILDREN WITH TRISOMY OF CHROMOSOME 21

FULL TEXT:

Abstract

Down syndrome is the most common chromosomal pathology. It occurs when, as a result of a random mutation, another chromosome appears in the 21st pair. Often, children with Down syndrome (DS) and related disorders have a lower IQ
level, severe forms of stereotypical behavior.
Aim: to study neurological conditions in children with DM. Conducting clinical neurological, neurophysiological and
audiological studies in 34 children (16 boys, 18 girls) with DM. The Stanford-Binet scale was used to determine the intellectual
status of children with DM. The manifestation of autistic disorders, somatic pathology, lack of speech activity are unfavorable prognostic factors in children with DM.

About the Authors

List of references

Madjidova Ya.N., Salikhova S.M.: Possible pathogenetic mechanisms of progression and the occurrence of intellectual and cognitive impairment in patients with Down syndrome, International Journal of Psychosocial and Rehabilitation, Scopus. -2020. -Vol.24, special issue 1. -P. 789-793.

Uryadnitskaya Natalia Anatolyevna / Down syndrome: features of neuroanatomy / Journal "Down Syndrome. XXI century”. - 2012. -Vol. 1 № 8. -R 57-62.

Goryanova A.B., Semenova N.A. Assessment of the rates of psychomotor development of children with Down syndrome. // Bulletin of the Russian State Medical University. Special issue. - 2013.-№. 1, -R.311.

Zhiyanova P.L., Polya E.V. Baby with Down syndrome: A book for parents. - Ed. 4-E. - M.: Charity Foundation "Downside-Up”, 2015. - R 195.

Kolcheva Yu.A. Pathogenetic foundations of neurological disorders in Down syndrome. BISSA 2017ю Vol. 6 -№. 4. -P. 19-21.

Medvedeva T.P. Development of cognitive activity of children with Down syndrome: manual. M.: Monolit, 2010 - R 80.

Odinikova G.Yu. Identification and overcoming of problems in the development of communication between a mother and a young child with Down syndrome: abstract. diss. ... cand. Psychological sciences: 13.00.03. - Moscow, 2015. - P. 26.

Bain S. K., Allin J. D. Book review: Stanford-Binet intelligence scales, fifth edition. Journal of Psycho educational Assessment. -2003. -№23. -R 87-95.

Raitano Lee N., Pennington B.F., Keenan J.M. Verbal short¬term memory deficits in Down syndrome: phonological, semantic, or both? J Neurodev Disord. -2010. -Vol. 2. №1. -R.9-25.

Jensen K.M. Primary care for adults with Down syndrome: adherence to preventive healthcare recommendations. J Intellect Disabil Res. -2013. Vol. 57. -№5. -P.409-421.

Ktosowska A. Down syndrome, increased risk of dementia and lipid disturbances. Dev Period Med. -2017. Vol. 21. -№1. -R 69-73.

Hankinson T.C. Craniovertebral function abnormalities in Down syndrome. Neurosurgery. -2010. - Vol. 66. №3. -P.32-38,

Sullivan W.F. Primary care of adults with intellectual and developmental disabilities: 2018 Canadian consensus guidelines. Can Fam Rhysician. -2018. -64. -№4. -R 254¬279,

Bunt C.W. Role of the family physician in the care of children with Down syndrome. Am Fam Physician. -2014. Vol. 90. -№12. -R851-858,

Bull M.J. Health supervision for children with Down syndrome. Pediatrics. 2011. -Vol. 128, -№ 2393-406,

Lau WL et al: Prevalence and parental awareness of hearing loss in children with Down syndrome. Chin Med J (Engl). -2015. -128 -№8. P.1091-1095.

Ilyina M.N. Psychological assessment of intelligence in children. Textbook. 2006.

Association for Children With Down Syndrome: Association for Children With Down Syndrome website. Accessed June 1, 2020. http://www.acds.org/

Norton M.E., et. al.: Cell-free DNA analysis for noninvasive examination of trisomy. N Engl J Med. -2015. -№372: -P. 1588-1599.

Baum R.A., Nash P.L., Foster J.E.A. Primary care of children and adolescents with Down syndrome: an update. Curr Probl Pediatr Adolesc Health Care. -2008. -№38. -P. 235-268.

De la Torre R., de Sola S., Hernandez G. Safety and efficacy of cognitive training plus epigallocatechin-3- gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomizes, placebo-controlled, phase 2 trial. Lancet Neurol. -2016. -№ 15. -P. 801-810.

Van Gameren-Oosterom H.B.M., Fekkes M., van Wouwe J.P., Problem behavior of individuals with Down syndrome in a nationwide cohort assessed in late adolescence. J Pediatr. -2013. -Vol. 163. -P. 1396-1401.

Verstegen R.H.J., Chang K.J.J., Kusters M.A.A. Clinical implications of immune-mediated diseases in children with Down syndrome. PediatrAllergyImmunol. -2020. -Vol. 31. №2. -P. 117-123. doi: 10.1111/pai.13133. Epub 2019 Oct 25.

How to Cite

S.M. Salikhova, & Y.N. Majidova. (2022). CLINICAL-NEUROLOGICAL AND NEUROPHYSIOLOGICAL CHANGES IN CHILDREN WITH TRISOMY OF CHROMOSOME 21. Herald of the National Children’s Medical Center, (2), 67–71. Retrieved from https://hnchmc.uz/index.php/jour/article/view/13
Views: 41